Limiting dilution assays in NSG mice using CD34+ CD38low CD123+ CD41– JAM-C+ or JAM-C– cells isolated from AML patients showed that JAM-C+ cells were 9.5-fold enriched in LSC compared with JAM-C– cells. The gene discussed is JAM3; the disease is acute myeloid leukemia.